Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo

A two-dose regimen of the Oxford-AstraZeneca (ChAdOx1) Covid-19 vaccine with an inter-dose interval of three months has been implemented in many countries with restricted vaccine supply. However, there is limited evidence for the effectiveness of ChAdOx1 by dose in elderly populations in countries w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hitchings, Matt D. T., Ranzani, Otavio T., Dorion, Murilo, D’Agostini, Tatiana Lang, de Paula, Regiane Cardoso, de Paula, Olivia Ferreira Pereira, de Moura Villela, Edlaine Faria, Torres, Mario Sergio Scaramuzzini, de Oliveira, Silvano Barbosa, Schulz, Wade, Almiron, Maria, Said, Rodrigo, de Oliveira, Roberto Dias, Silva, Patricia Vieira, de Araújo, Wildo Navegantes, Gorinchteyn, Jean Carlo, Andrews, Jason R., Cummings, Derek A. T., Ko, Albert I., Croda, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553924/
https://www.ncbi.nlm.nih.gov/pubmed/34711813
http://dx.doi.org/10.1038/s41467-021-26459-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553924/
https://www.ncbi.nlm.nih.gov/pubmed/34711813
http://dx.doi.org/10.1038/s41467-021-26459-6

Ejemplares similares